Tyme Technologies : Annual Report (Form 10-K)

tyme-10k_20220331.htm

Table of Contents



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549



... | May 25, 2022

Related Keywords

New York ,United States ,Japan ,United Kingdom ,Texas ,Florida ,Delaware ,California ,Santa Monica ,Washington ,Canada ,Russia ,Ukraine ,Germany ,New Jersey ,Monte Carlo ,Bedminster ,Maryland ,France ,Georgetown University ,District Of Columbia ,Americans ,America ,American ,Janm Van Tornout ,Barbarac Galaini ,James Biehl ,Jonathan Eckard ,Timothyc Tyson ,Jan Van Tornout ,Frank Mongiello ,Sant Chawla ,Steve Hoffman ,Frank Porfido ,Michael Demurjian ,Richard Cunningham ,Trickett Wendler ,Us Congress ,Revenue Service ,Health Care Reform Lawarealsoinvalid On ,Investor Relations Department ,Transaction Committee ,Us Court ,Us District Court ,Trademark Office ,While The Company ,International Regulation ,Global Group Enterprises Corp ,Exchange Agreements ,Public Company Accounting Oversight Board United States ,Centers For Disease ,Exchange Agreement ,Centers For Medicare Medicaid Services ,Tyme Inc ,World Health Organization ,Contract Clinical Research Organization ,European Organisation For Research ,Exchange Agreement See Historical Financings ,Health Care ,Key Product Properties ,Contract Service Providers ,Health Care Reform Cadillac ,Joseph Ahmed Foundation ,Tumor Targeting Technology ,Incorporation Or Organization ,Seriesa Preferred Stock Of The Company ,Drug Administration Modernization ,Eu Commission ,Health Care Reform Law On ,Liability Company ,Tyme Technologies Inc ,Medicaid Services ,Division Of Oncology ,Medicaid Drug Rebate Program ,Share Exchange Agreements ,Smaller Reporting Company ,Us Department Of Health ,Preclinical Pipeline Program ,Pancreatic Cancer Action Network ,Committee On Deficit Reduction ,Health Care Reform ,Trust Company ,Public Health Service ,European Medicines Agency ,Fast Track Program ,Office Of Oncologic Diseases ,Public Health Service Act ,Office Of Inspector ,Health Insurance Portability ,Nasdaq ,Development Expenses ,Clinical Health Act ,Centers For Medicare ,Ethics Committee ,Strategic Planning Committee Of The Board ,Moelis Company ,Clinical Health ,Department Of Justice ,Drug Administration ,Children Health Insurance Program ,European Commission ,Eagle Pharmaceuticals ,Data Monitoring Committee ,Syneos Health ,Exchange Commission ,Health Care Reform Lawis ,Health Care Reform Lawmarketplace ,Florida As Global Group Enterprises Corp ,Securities Exchange ,Texas Us District Court ,Us Department Of Justice ,Commission File No ,Biomarker Research ,Tymeand Eagle Pharmaceuticals Inc ,Clinical Research Funding ,Drug Administration Safety ,Portfolio Development Strategy ,European Union ,Health Care Reform Law ,Corporation Law ,Public Company Accounting Oversight Board ,United States Department Of Health ,Health Information Technology For Economic ,Compassionate Use Program ,Eagle Pharmaceuticals Inc ,Human Services ,Growth Company ,District Court ,Sarcoma Oncology Center ,Scientific Affairs ,Company Common Stock ,Eastern Cooperative Oncology Group Performance Status ,Outcomes Research Institute ,Exact Name ,Its Charter ,Principal Executive Offices ,Zip Code ,Securities Exchange Act ,Interactive Data File ,Regulations T ,Sarbanes Oxley Act ,Proxy Statement ,Annual Report ,Tyme Technologies ,Insurance Portability ,Accountability Act ,Information Technology ,States Department ,Economic Security ,Sponsoring Organizations ,Treadway Commission ,Drug Administration Modernization Act ,Cosmetic Act ,Oxley Act ,States Patent ,Strategic Options ,Strategic Planning Committee ,Member Timothy ,Cancer After ,Data Monitor ,Principal Investigator ,Mayo Clinic ,Investigational New Drugs ,Use Patients ,Clinical Benefit ,Compassionate Use Patients ,Trial Reported ,Panc Part ,Discontinuing Programs ,Metastatic Pancreatic Cancer ,Precision Promise ,Development Strategy ,Warburg Effect ,Federal Food ,Oncologic Diseases ,Standard Review ,Related Requirements ,Innovation Act ,Breakthrough Therapy ,Breakthrough Therapy Designation ,Hatch Waxman Act ,Abbreviated New Drug Application ,Napproved Drug Products ,Therapeutic Equivalence Evaluations ,Orange Book ,Orange Book Listed ,Orphan Drug Act ,Healthcare Laws ,Compliance Requirements ,Inspector General ,Drug Master Files ,Corporate Governance Guidelines ,Securities Purchase Agreement ,Co Promotion Agreement ,Global Group Enterprises ,Corporate History ,Significant Organizational ,One Pluckemin Way ,Market Sales ,Open Market Sale ,Common Stock ,Sale Agreement ,Exchange Shares ,Warrant Exchange Agreement ,Share Leak Out Agreement ,Quarterly Reports ,Current Reports ,United States Securities ,Investor Relations ,Owning Our ,Regulatory Approval ,Financial Condition ,Government Regulations ,Owning Our Stock ,Chief Science Officer ,Chief Operating Officer ,Nasdaq Capital Market ,Nasdaq Capital ,Nasdaq Listing Rule ,Preferred Stock ,Incentive Plan ,Delaware General Corporation Law ,Securities Act ,Data Safety Monitoring Board ,Compassionate Use ,Compassionate Use Patient ,Prescription Drug Price Relief Act ,Medicare Prescription Drug ,Modernization Act ,Medicare Modernization Act ,Patient Protection ,Affordable Care Act ,Education Reconciliation Act ,Care Reform ,President Obama ,Budget Control Act ,Joint Select Committee ,Deficit Reduction ,American Taxpayer Relief Act ,Coronavirus Aid ,Most Favored Nation ,Northern California ,Joseph Ahmed ,Data Protection Regulation ,Cooperation Agreement ,United States Patent ,Hatch Waxman Amendments ,Drug Price Competition ,Patent Term Restoration Act ,False Claims Act ,Anti Kickback Statute ,Patient Centered Outcomes Research Institute ,Jordan Mclinn ,Matthew Bellina Right ,Try Act ,Tax Cuts ,Jobs Act ,Tax Act ,Health Care Reform Law Mandated ,Bipartisan Budget Act ,Health Care Reform Lawarealsoinvalid On June ,Supreme Courtruled ,Fifth Circuit ,President Biden ,Health Care Reform Law On March ,American Rescue Plan Act ,American Economy ,Addressing High Drug ,Drug Pricing ,Build Back Better Act ,Health Care Reform Act ,Stark Law ,Health Insurance Program ,Health Information Technology ,California Consumer Privacy Act ,False Claims ,Internal Revenue Service ,Foreign Corrupt Practices Act ,Trade Control ,Bribery Act ,Trade Control Laws ,Exchange Act ,Regulations K ,Business Experience ,Chief Executive Officer ,Chief Legal Officer ,Chief Scientific Affairs Officer ,Chief Business Officer ,Principal Accounting Officer ,Corporate Controller ,Chief Financial Officer ,Chief Medical Officer ,Continental Stock ,Shares Outstanding ,Issuance Under Equity Compensation Plan ,Compensation Plans ,Preclinical Pipeline Programs ,Nasdaq Stock Market ,Accounting Policies ,Recent Accounting Pronouncements ,Consolidated Financial Statements ,Stock Compensation ,Stockholder Equity ,Black Scholes ,Recent Accounting ,Year Ended March ,Release Agreement ,General Release Agreement ,Historical Financings ,Net Loss ,Adjusted Net ,Net Loss Per Share ,Adjusted Basic ,Diluted Net Loss Per ,Capital Resources ,Capital Requirements Outlook ,Capital Requirements ,Registration Statement ,Sales Agreement ,Drug Supply Agreement ,Comprehensive Loss ,Years Ended March ,Cash Flows ,Cash Flow Information ,Significant Accounting Policies ,Consolidated Statements ,Equity Securities ,Fair Value Measurements ,Diluted Loss Per ,Equity Incentive Plan ,Income Taxes ,Income Taxesand ,Financial Instruments Credit Losses ,Financial Instruments ,Own Equity ,Loss Per Common ,Scientific Advisory Board Compensation ,Nc Stock Exchange ,News ,Information ,Press Release ,Table ,F ,United ,Securities ,End ,Xchange Tyme Us90238j1034 ,